PLIANT THERAPEUTICS, INC. (PLRX) Depreciation USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Pliant Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2024.
  • Pliant Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $513 K, a 13.5% increase year-over-year.
  • Pliant Therapeutics, Inc. Depreciation for the twelve months ending March 31, 2024 was $1.9 M, a 4.51% increase year-over-year.
  • Pliant Therapeutics, Inc. annual Depreciation for 2023 was $1.84 M, a 0.99% increase from 2022.
  • Pliant Therapeutics, Inc. annual Depreciation for 2022 was $1.82 M, a 18.8% increase from 2021.
  • Pliant Therapeutics, Inc. annual Depreciation for 2021 was $1.54 M, a 17.2% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.9 M $513 K +$61 K +13.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $1.84 M $489 K +$21 K +4.49% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $1.82 M $500 K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.82 M $400 K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.82 M $452 K -$3 K -0.66% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $1.82 M $468 K +$92 K +24.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $1.73 M $500 K +$100 K +25% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.63 M $400 K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $1.63 M $455 K +$96 K +26.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $1.54 M $376 K -$22 K -5.53% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $1.56 M $400 K +$100 K +33.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $1.46 M $400 K +$100 K +33.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $1.36 M $359 K +$47 K +15.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $1.31 M $398 K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $300 K $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $300 K +$100 K +50% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $312 K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q3 2019 $300 K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $200 K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.